Howard Univ. Washington DC NICHD CRS

Washington, District of Columbia 20060

We've found

1 trials

at this facility

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Washington DC,

Use our guide to learn which trials are right for you!